Clinical Report: Impact of DAPT Duration on Outcomes After DCB PCI

Overview

This meta-analysis evaluates the optimal duration of dual antiplatelet therapy (DAPT) following percutaneous coronary intervention (PCI) with drug-coated balloons (DCB). It highlights the association between DAPT duration and bleeding and ischemic events, suggesting that shorter DAPT regimens may be safe and effective.

Background

The duration of DAPT after PCI is critical for balancing the risk of thrombotic events against bleeding complications. While guidelines exist for DAPT duration following drug-eluting stent (DES) implantation, recommendations for DCB remain less defined. Understanding the implications of DAPT duration in DCB procedures is essential for optimizing patient outcomes and minimizing adverse events.

Data Highlights

No specific numerical data was provided in the source material.

Key Findings

• Current guidelines recommend at least 6 months of DAPT for DES, but DCB lacks specific recommendations.
• Shorter DAPT regimens may be safe for patients undergoing DCB angioplasty, particularly in high bleeding risk scenarios.
• Emerging studies indicate that 1 month of DAPT may be sufficient for certain patient populations treated with DCB.
• Meta-analysis findings suggest a need for further research to establish standardized DAPT protocols for DCB procedures.
• Clinical outcomes after DCB angioplasty show comparable efficacy to DES, warranting further exploration of DAPT duration.

Clinical Implications

Clinicians should consider individual patient risk factors when determining DAPT duration after DCB procedures. The potential for shorter DAPT regimens may reduce bleeding complications without compromising ischemic protection, particularly in high-risk patients.

Conclusion

The findings from this meta-analysis underscore the necessity for further research to clarify optimal DAPT duration following DCB angioplasty. Establishing evidence-based guidelines could enhance patient safety and treatment efficacy.

Related Resources & Content

1. Clinical Research in Cardiology, 2025 -- Duration of dual antiplatelet therapy and risk of stent thrombosis in patients undergoing complex PCI: a meta-analysis
2. Clinical Research in Cardiology, 2025 -- Preoperative Dual Antiplatelet Therapy with Aspirin and Ticagrelor in Acute Coronary Syndrome Patients Undergoing Emergency Aortocoronary Bypass Surgery
3. Clinical Research in Cardiology, 2015 -- Evaluation of the Antirestenotic Effectiveness of Two Paclitaxel-Coated Drug-Eluting Balloons for Managing In-Stent Restenosis
4. Clinical Research in Cardiology, 2012 -- Efficacy of Drug-Eluting Balloons for Managing In-Stent Restenosis: A Meta-Analysis of Randomized Controlled Trials
5. ACC, AHA Issue New Acute Coronary Syndromes Guideline - American College of Cardiology, 2025
6. Drug-Eluting Balloon in stable and Unstable angina: a randomized controlled non-inferiority Trial - American College of Cardiology
7. FDA - AGENT Paclitaxel-Coated Balloon Catheter
8. ACC, AHA Issue New Acute Coronary Syndromes Guideline - American College of Cardiology
9. Drug-Eluting Balloon in stable and Unstable angina: a randomized controlled non-inferiority Trial - American College of Cardiology